Trial intelligence / Profile preview

Dexmedetomidine for heart rate control before cardiopulmonary bypass in tight mitral stenosis

ACTRN12613000495729Phase 3Recruiting

Sponsor
South Valley University
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in mitral stenosis (MS) comparing Dexmedetomidine with Placebo saline (2 arms). Primary endpoint: Heart rate changes. Started Nov 2011; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

mitral stenosis (MS)

Beyond the preview

Go deeper on ACTRN12613000495729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000495729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call